• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

啮齿动物炎症性肠病的遗传和自发模型:黏膜免疫调节异常的证据。

Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.

作者信息

Powrie F, Leach M W

机构信息

DNAX Research Institute of Molecular and Cellular Biology Inc. Palo Alto, CA 93404, USA.

出版信息

Ther Immunol. 1995 Apr;2(2):115-23.

PMID:8729882
Abstract

A number of models of spontaneous chronic intestinal inflammation in mice and rats have recently been developed. A characteristic of the majority of these models is that disease developed as a consequence of immune manipulations, suggesting a central role for the immune system in the regulation of intestinal inflammation. Analysis of cytokine patterns in disease showed elevations in TNF-alpha and IFN-gamma, characteristic of the T-helper-1 (Th1) pathway, implicating Th1 cells and their cytokines in disease pathogenesis. Strikingly, inflammation did not develop in mice maintained in germ-free conditions, suggesting disease may develop due to a dysregulated inflammatory response to components of the normal flora. Evidence from a number of these models suggests that this potentially pathogenic inflammatory response does not develop in normal animals as it is actively inhibited by a population of CD4+ alpha beta + regulatory T cells and immunosuppressive cytokines such as IL-10 and TGF-beta 1. These new models will allow further investigation into the mechanisms of natural immune regulation and protection in the intestinal tract and how these mechanisms relate to the etiopathogenesis of inflammatory bowel disease (IBD). Furthermore, these models should provide useful insights for the design of effective immunomodulatory therapies for the treatment of IBD in humans.

摘要

最近已经开发出了许多小鼠和大鼠自发性慢性肠道炎症模型。这些模型中的大多数的一个特点是,疾病是免疫操纵的结果,这表明免疫系统在肠道炎症调节中起核心作用。对疾病中细胞因子模式的分析显示,肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)升高,这是辅助性T细胞1(Th1)途径的特征,表明Th1细胞及其细胞因子参与了疾病的发病机制。引人注目的是,在无菌条件下饲养的小鼠中不会发生炎症,这表明疾病可能是由于对正常菌群成分的炎症反应失调所致。来自许多这些模型的证据表明,这种潜在的致病性炎症反应在正常动物中不会发生,因为它受到一群CD4+αβ+调节性T细胞以及免疫抑制细胞因子(如白细胞介素-10(IL-10)和转化生长因子-β1(TGF-β1))的积极抑制。这些新模型将允许对肠道中天然免疫调节和保护机制以及这些机制与炎症性肠病(IBD)的病因发病机制之间的关系进行进一步研究。此外,这些模型应该为设计用于治疗人类IBD的有效免疫调节疗法提供有用的见解。

相似文献

1
Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.啮齿动物炎症性肠病的遗传和自发模型:黏膜免疫调节异常的证据。
Ther Immunol. 1995 Apr;2(2):115-23.
2
Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.肠道炎症的动物模型:炎症性肠病发病机制的线索
Novartis Found Symp. 2004;263:164-74; discussion 174-8, 211-8.
3
Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.稳态(IL-7)和效应(IL-17)细胞因子作为炎症性肠病最佳治疗策略中不同但互补的靶点。
Curr Opin Gastroenterol. 2009 Jul;25(4):306-13. doi: 10.1097/MOG.0b013e32832bc627.
4
Immune dysfunction in inflammatory bowel disease.炎症性肠病中的免疫功能障碍。
Transl Res. 2007 Apr;149(4):173-86. doi: 10.1016/j.trsl.2006.11.009.
5
Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses.肠道中的免疫调节:效应性T细胞反应与调节性T细胞反应之间的平衡行为。
Ann N Y Acad Sci. 2004 Dec;1029:132-41. doi: 10.1196/annals.1309.030.
6
Lessons from genetic models of inflammatory bowel disease.炎症性肠病遗传模型的经验教训。
Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):163-5.
7
CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.细菌DNA的CpG基序通过非抗原依赖性耐受诱导在炎症性肠病小鼠模型中发挥保护作用。
Gastroenterology. 2009 Jan;136(1):278-87. doi: 10.1053/j.gastro.2008.09.022. Epub 2008 Sep 25.
8
Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.动物模型在炎症性肠病发病机制及治疗中的作用
Scand J Gastroenterol Suppl. 1997;223:99-104.
9
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.共生菌(正常微生物群)、黏膜免疫与慢性炎症及自身免疫性疾病。
Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005.
10
Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.使用定量实时逆转录聚合酶链反应(RT-PCR)测量患有炎症性肠病的猫的肠道活检组织中细胞因子mRNA的表达。
Vet Immunol Immunopathol. 2006 Oct 15;113(3-4):404-14. doi: 10.1016/j.vetimm.2006.06.010. Epub 2006 Aug 1.

引用本文的文献

1
Acute Administration of Ojeok-san Ameliorates Pain-like Behaviors in Pre-Clinical Models of Inflammatory Bowel Diseases.急性给予莪术三醇可改善炎症性肠病临床前模型中的疼痛样行为。
Nutrients. 2023 Mar 23;15(7):1559. doi: 10.3390/nu15071559.
2
Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn's disease patients with isolated anastomotic lesions.中性粒细胞与淋巴细胞比值对孤立性吻合口病变的克罗恩病患者术后复发的预测作用
Therap Adv Gastroenterol. 2023 Mar 31;16:17562848231165129. doi: 10.1177/17562848231165129. eCollection 2023.
3
Total CD3 T Cells Are Necessary and Sufficient to Induce Colitis in Immunodeficient Mice With Dendritic Cell-Specific Deletion of TGFbR2: A Novel IBD Model to Study CD4 and CD8 T-Cell Interaction.
总 CD3 T 细胞是诱导树突状细胞特异性 TGFbR2 缺失免疫缺陷小鼠结肠炎所必需和充分的:研究 CD4 和 CD8 T 细胞相互作用的新型 IBD 模型。
Inflamm Bowel Dis. 2020 Jan 6;26(2):229-241. doi: 10.1093/ibd/izz191.
4
Differential Susceptibility to T Cell-Induced Colitis in Mice: Role of the Intestinal Microbiota.小鼠 T 细胞诱导结肠炎的差异易感性:肠道微生物群的作用。
Inflamm Bowel Dis. 2018 Jan 18;24(2):361-379. doi: 10.1093/ibd/izx014.
5
Chemokine and cytokine levels in inflammatory bowel disease patients.炎症性肠病患者体内趋化因子和细胞因子水平
Cytokine. 2016 Jan;77:44-9. doi: 10.1016/j.cyto.2015.10.008. Epub 2015 Oct 29.
6
Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut.Gimap5在维持肠道外周免疫耐受和T细胞稳态中的核心作用。
Mediators Inflamm. 2015;2015:436017. doi: 10.1155/2015/436017. Epub 2015 Apr 7.
7
The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease.瘦素拮抗剂在炎症性肠病中的潜在治疗作用。
Int Rev Immunol. 2014 Jan;33(1):23-33. doi: 10.3109/08830185.2013.809071. Epub 2013 Jul 10.
8
The gut microbiota and mucosal T cells.肠道微生物群和黏膜 T 细胞。
Front Microbiol. 2011 May 26;2:111. doi: 10.3389/fmicb.2011.00111. eCollection 2011.
9
Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis.副干酪乳杆菌可减轻实验性结肠炎过继转移小鼠模型中的肠道炎症。
Clin Dev Immunol. 2011;2011:807483. doi: 10.1155/2011/807483. Epub 2011 Jul 25.
10
Novel topical therapies for distal colitis.远端结肠炎的新型局部治疗方法。
World J Gastrointest Pharmacol Ther. 2010 Oct 6;1(5):87-93. doi: 10.4292/wjgpt.v1.i5.87.